Results of the Home Monitoring of the Eye (HOME) study, show that participants at high risk for developing wet age-related macular degeneration (wAMD) using the ForeseeHome monitoring device strategy had significantly better preservation of their visual acuity than those used standard monitoring techniques.
The HOME Study was a collaborative effort led by the National Eye Institute (NEI) to evaluate the performance of Notal Vision’s ForeseeHome device and self-monitoring strategy. 87% of eyes in the ForeseeHome device arm of the study maintained visual acuity of 20/40 or better compared to 62% in the standard care alone arm. Median acuity among device users at the time of choroidal neovascularization (CNV) diagnosis was 20/32.
Among individuals using standard care methods for monitoring, only 55% of those that progressed noted symptoms at home that led them to request an examination. 80% of the participants in the device monitoring group returned sooner than a scheduled appointment, due to a change found by the device or to self-monitoring. This was associated with a greater degree of vision preservation at CNV diagnosis among individuals who returned promptly for examination.
Access the HOME Study report.
